¡¶ÇàÆ»¹ûÓ°Ôºyy4100Ãâ·Ñ¡·Â×ÀíÃâ·Ñ²¥·Å - ·çÔÆÓ°ÊÓ"/> ËûÆÈȱ·¦´ýÒª½«Õâ¸öÕæÏà¸æË߸¸Çס£"/>

ÌÚ²©tengbo9885¹ÙÍø

¡¶ÇàÆ»¹ûÓ°Ôºyy4100Ãâ·Ñ¡·Â×ÀíÃâ·Ñ²¥·Å - ·çÔÆÓ°ÊÓ

¡¶ÇàÆ»¹ûÓ°Ôºyy4100Ãâ·Ñ¡·Â×ÀíÃâ·Ñ²¥·Å - ·çÔÆÓ°ÊÓ

¡¶¡¶ÇàÆ»¹ûÓ°Ôºyy4100Ãâ·Ñ¡·Â×ÀíÃâ·Ñ²¥·Å - ·çÔÆÓ°ÊÓ¡·¾çÇé¼ò½é£ºËûÆÈȱ·¦´ýÒª½«Õâ¸öÕæÏà¸æË߸¸Ç×ʱ¼äÔÚÒ»µãÒ»µÎµÄÁ÷ÊÅÇàÍ­Ôªº£µÄË®ÃæÒ²ÔÚÐìÐìµØÏ½µ¡¶ÇàÆ»¹ûÓ°Ôºyy4100Ãâ·Ñ¡·Â×ÀíÃâ·Ñ²¥·Å - ·çÔÆÓ°ÊÓĽÈݸ´Õ¾ÆðÉíÀ´΢΢Ô˶¯Ò»Ï¸ÐÊÜËÄÖ«¶¼É¢¼ÜÁ˲»¹ýÕâµãÌÛÍ´±ÈÆðÐÞÁ¶Ï´Ëè¾­µÄÍ´¿àÒ²²»ËãʲôÈËÐľÍÊǽ­ºþÄܹ»ÌýÐİ®µÄÈ˵¯Ò»ÇúЦ°Á½­ºþ¼´ÊÇ×ÓÅ®Ç鳤

¡¶¡¶ÇàÆ»¹ûÓ°Ôºyy4100Ãâ·Ñ¡·Â×ÀíÃâ·Ñ²¥·Å - ·çÔÆÓ°ÊÓ¡·ÊÓÆµËµÃ÷£ºÁ½¿Å¸ß±¬µ¯µÄÂäµãÏà²î°ÙÃ׿Éʬº£±é²¼µÄµÄ¹æÄ£²»Ö¹°ÙÃ×Ⱥ¼¯ÔÚÒ»ÆðµÄɥʬº£ÈÃÈ˲»¿ÉÇø·ÖËüÃÇ´øµØÓм¸¶àË×»°ËµÈËÉÏÒ»ÍòÎÞ±ßÎÞÑÄÕâÀïµÄɥʬ¿É¾ø¶Ô²»Ö¹Ò»ÍòÉùÊÆºÕºÕµÄɥʬÏñ´ÓÌìÑÄÇãÈ÷µÄÐþÉ«º£ÀËÖð²½Ó¿¹ýÀ´ËûÃÇÔÚÈü³¡ÉϵÄÿһ´ÎÅäºÏ¶¼ÈÃÈËÑÛǰһÁÁËÆºõËûÃÇÖ®¼äµÄÿһ¸öÑÛÉñ¡¢Ã¿Ò»¸öÐж¯¶¼ÒѾ­¾­ÓÉÁËǧ°Ù´ÎµÄÄ¥Á·ÍíÉÏÄþÄþÓÉÓÚÕÉ·òµÄ̬¶È¶øÕ·×ª·´²à˯²»×Å¿ÉÕÉ·òÄØȴ˯µÄ´òºôààµÚ¶þÌì¾ÍÏñ¸öûÊÂÈËÒ»Ñù²»ÒÔΪ×Ô¼º×ö´íÁË

±»ÕÅСǿ¿ØÖÆÔÚÊÖÖеÄÉÐÓоü¶ÓÖܽܵÄÌáÐѺܵ½Î»ÕÅÐ¡Ç¿Ö®Ç°Ò»ÆøÖ®ÏÂ×¼±¸½«Ò°Õ½²½¶ÓµÄÖ÷×ùÈÎÃüΪÇÇÏÖÔÚÏëÆðÀ´ËûÒ²ÒÔΪ²»µ±ÊÂʵÇÇÊÇÍâ¹úÈËսʿÃDz»»áϰ¹ßÔÚÍâ¹úÈ˵ÄÖ¸»ÓÏÂÕ½¶·ÒÔÊÇËûÕÕ¾ÉÈÃÕÔ¿¡ÈÏÕæ²»¹ýÕÔ¿¡Ö»ÈÏÕæÔÝʱ»ùµØµÄ×¤ÊØ²½¶ÓÍâDz²½¶ÓÒÔºó¾ÍÊÇÐíºÆÈÏÕæ¶øÇÇ×÷ΪÐíºÆµÄ°ïÊÖÌî²¹ÐíºÆÂÄÀúµÄȱ·¦MGBAÊÇ賦µÀÓë´óÄÔÖÐÊàÉñ¾­ÏµÍ³Ö®¼äͨ¹ýÉñ¾­¡¢¼¤Ëؼ°ÃâÒß;¾¶¾ÙÐеÄË«Ïòµ÷ÀíÓëÏàͬϵͳ¶Ôά³Ö»úÌåÕý³£ÐÄÀíÔ˶¯¾ßÓÐÖ÷Òª×÷ÓÃ[85]MGBAÖ÷ÒªÓÉÖÐÊàÉñ¾­ÏµÍ³¡¢Éñ¾­ÄÚÉøÍ¸ÏµÍ³¡¢Éñ¾­ÃâÒßϵͳ¡¢×ÔÖ÷Éñ¾­ÏµÍ³¡¢³¦Éñ¾­ÏµÍ³¡¢³¦µÀ΢ÉúÎïȺ¡¢SCFAs×é³É[86]ÉãÈëµÄÓªÑøÒòËØÔÚ³¦µÀ¾úȺµÄ×÷ÓÃϱ¬·¢ÆÊÎöÈçË«Æç¸Ë¾ú¡¢ÆÕÀ×ÎÖÊϾú¡¢Ã«Âݾú¿Æ¡¢Ëó×´Ñ¿°û¸Ë¾úµÈ³¦µÀ¾úȺ¿É½«ÓªÑøÒòËØÆÊÎö±¬·¢SCFAsÕâЩSCFAs¿É¼¤»î³¦ÄÚÉøÍ¸Ï¸°û£¨enteroendocrine cellsEECs£©´ÙʹÆä±¬·¢¶àÖÖ³¦µÀ¼¤ËذüÀ¨µ¨ÄÒËõ¶ÌËØ£¨cholecystokininCCK£©¡¢ÒȸßѪÌÇËØÑùëÄ-1£¨glucagon-like peptide-1GLP-1£©¡¢Î¸ÃÚËáµ÷ÀíËØ£¨oxyntomodulinOXM£©¡¢ÀÒÀÒëÄ£¨peptide YYPYY£©¡¢ÊÝËØ¼°´ÙÉú³¤¼¤ËصÈ[87]ÉÏÊö³¦µÀ¼¤ËØÓëÉñ¾­ÔªÊÜÌåÍŽáºóͨ¹ý¼¤»îÖÜΧÉñ¾­Ôª»òÖ±½ÓÏòÖÐÊàÉñ¾­ÏµÍ³´«ËÍÄÚÉøÍ¸ÐźÅ´Ó¶øÆô¶¯³¦-ÄÔÖá¿ØÖÆÊ³ÎïÉãÈëÒÔά³ÖÄÜÁ¿Æ½ºâ[88-89]Ö÷Òª¼ÓÈëµÄÉñ¾­Ôª°üÀ¨Éñ¾­ëÄY£¨neuropeptide YNPY£©/´ÌÊóÏà¹ØëÄ£¨agouti-related proteinAGRP£©Éñ¾­ÔªÓë°¢ºÚÆ¤ËØÔ­£¨proopiomelanocortinPOMC£©/¿É¿¨Òò-±½±û°·µ÷Àíת¼ëÄ£¨cocaine and amphetamine-regulated transcriptCART£©Éñ¾­Ôª[90]£»Õâ2ÖÖÉñ¾­Ôª¿ÉÏ໥×è¶Ï[91]ÅäºÏ¼ÓÈëµ÷ÀíʳÓûºÍÄÜÁ¿´úлÉñ¾­ÔªÓë¼¤ËØ×÷ΪMGBAÖáÖÐת´ïÐÅÏ¢µÄÐźŷÖ×Ó¼ÓÈë×Ô賦µÀÖÁÖÐÊàÉñ¾­ÏµÍ³µÄÍêÕû×Ô϶øÉϵĸº·´Ïìµ÷Àí»ØÂ·È·±£»úÌåµÄÄÜÁ¿Æ½ºâµÃÒÔά³Ö[92]

һֱûÓÐ×÷ÉùµÄ»ÆÍ¢Î°ÓïÑÔÁ˹ØÓÚ»ÆÍ¢Î°ÕÅСǿÏàµ±ÖØÊÓ»ÆÍ¢Î°Ë¼Á¿µÄ¹¤¾ß½ÏÁ¿ÖÜȫ͎᷽·½ÃæÃæµÄÖÖÖÖÒòËØµÃ³öµÄ½áÂÛÒ²ÊÇ×îÌù½üÏÖʵµÄÔÂÈçÕâ²ÅÏëÆðÈ¥Äê¶ËÎçÁúÖÛÈüʱÕò¶«Í·ÍõÍÀ»§µÄ¶À×Ó°¢ÂúʧÉ÷µøÈëÀì½­´òÀÌÁËÈýÈÕ²ÅÕÒµ½ÒÅÌåÆäʱËý»¹Ëæ×ÅĸÇ×È¥Ë͹ýֽǮ¿ÉÑÛǰµÄÉÙÄêÏÔןͰ¢ÂúÄêËêÏà·ÂÔõ»áÄð³ÉÕ⸱ÈÝò

µ¼ÑÝ£º
¸üУº

2025-09-26 17:34:30

±¸×¢£º
¹úÓï
ÆÀ¼Û£º
¡¶ÇàÆ»¹ûÓ°Ôºyy4100Ãâ·Ñ¡·Â×ÀíÃâ·Ñ²¥·Å - ·çÔÆÓ°ÊÓ
Ê×Ò³
Ó°Ï·
Ò»Á¬¾ç
×ÛÒÕ
¶¯Âþ
APP
ÍøÕ¾µØÍ¼